Loading...

Catherine Park, MD

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
Phone415-353-7183
vCardDownload vCard
    Other Positions
    Title(s)Interim Chair, Radiation Oncology


    Collapse Research 
    Collapse Research Activities and Funding
    A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
    NIH/NCI R01CA174929May 5, 2014 - Feb 28, 2019
    Role: Principal Investigator
    Stromal MRI characteristics &gene expression profiles as predictors of outcome
    NIH R21CA152499Jul 28, 2010 - Jun 30, 2013
    Role: Principal Investigator
    Manipulating b1 integrin to enhance radiation therapy for breast cancer
    NIH R01CA124891Apr 4, 2008 - Jun 30, 2013
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res. 2008 Jun 01; 68(11):4398-405. PMID: 18519702; PMCID: PMC3719863.
      View in: PubMed, PubMed Central
    2. Park CK, Miller C, Lawrence G. Addison's disease from non-Hodgkin's lymphoma with normal-size adrenal glands. J Clin Oncol. 2007 Jun 01; 25(16):2322-4. PMID: 17538179.
      View in: PubMed
    Catherine's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (19) concept(s)
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑